Back

Exploratory study on the inhibitory effect of dihydrotanshinone on RNA-binding protein (HuR) in the treatment of pulmonary heart disease with right ventricular fibrosis

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pathophysiology and mechanisms Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Xi-Yong Yu

Guangzhou Medical University, Guangzhou (China)

7 More presentations in this session

Presentation thumbnail
Plasma apelin levels in pulmonary arterial hypertension: a potential early diagnostic biomarker?
Doctor C. Tunca (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Multi-omics interrogation of energy metabolism reveals novel causal targets in pulmonary arterial hypertension
Mr S. Hou (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular and metabolic comorbidities shape endothelial dysfunction in pulmonary arterial hypertension and may influence treatment: insights from a multicenter translational network
Associate Professor R. Madonna (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
CCR6⁺ T cells as potential drivers of inflammation in chronic thromboembolic pulmonary hypertension
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Peripheral T-cell remodeling in long-standing PAH: CD4+ reduction and CCR6 enrichment
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension: pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Interleukin-22–STAT3 Signaling Preserves Structural Integrity in the Pressure-Overloaded Right Ventricle
28 August 2026
thumbnail
Congress Presentation
666-15 protects rats against MCT-induced pulmonary arterial hypertension by inhibiting mitochondrial fission
30 August 2025
thumbnail
Congress Presentation
Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model
25 August 2023
thumbnail
Congress Presentation
Urinary proteomic analysis for biomarker discovery of pulmonary arterial hypertension-induced right ventricular failure
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources